SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: October 17, 1995
C. R. BARD, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
New Jersey 1-6926 22-1454160
(STATE OF COMMISSION FILE NUMBER IRS EMPLOYER
INCORPORATION) IDENTIFICATION NO.
730 Central Avenue, Murray Hill, New Jersey
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
07974
(ZIP CODE)
(908) 277-8000
(REGISTRANT'S TELEPHONE NUMBER)
<PAGE>
Item 5. Other Events
On October 9, 1995 Trimedyne, Inc., a medical device manufacturer,
filed a complaint in state court in California alleging breach of
contract, fraud and misrepresentation by the Company in connection
with its performance under a development, supply and license
agreement concerning side-firing laser products. The complaint
seeks significant amounts for both compensatory and punitive
damages. The Company intends to vigorously defend itself against
such suit and believes that it has meritorious defenses and that
the damages claimed are grossly exaggerated.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
C. R. BARD, INC.
(Registrant)
By:
William C. Bopp
Executive Vice President
and Chief Financial Officer
Dated: October 17, 1995
